Your browser doesn't support javascript.
loading
Targeted inhibition of PI3Kα/δ is synergistic with BCL-2 blockade in genetically defined subtypes of DLBCL.
Bojarczuk, Kamil; Wienand, Kirsty; Ryan, Jeremy A; Chen, Linfeng; Villalobos-Ortiz, Mariana; Mandato, Elisa; Stachura, Joanna; Letai, Anthony; Lawton, Lee N; Chapuy, Bjoern; Shipp, Margaret A.
Afiliação
  • Bojarczuk K; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA; and.
  • Wienand K; Department of Experimental Hematology, Institute of Hematology and Transfusion Medicine, Warsaw, Poland.
  • Ryan JA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA; and.
  • Chen L; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA; and.
  • Villalobos-Ortiz M; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA; and.
  • Mandato E; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA; and.
  • Stachura J; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA; and.
  • Letai A; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA; and.
  • Lawton LN; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA; and.
  • Chapuy B; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA; and.
  • Shipp MA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA; and.
Blood ; 133(1): 70-80, 2019 01 03.
Article em En | MEDLINE | ID: mdl-30322870
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Pirimidinas / Quinazolinas / Sulfonamidas / Linfoma Difuso de Grandes Células B / Compostos Bicíclicos Heterocíclicos com Pontes / Proteínas Proto-Oncogênicas c-bcl-2 / Sinergismo Farmacológico / Classe I de Fosfatidilinositol 3-Quinases Idioma: En Ano de publicação: 2019 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Pirimidinas / Quinazolinas / Sulfonamidas / Linfoma Difuso de Grandes Células B / Compostos Bicíclicos Heterocíclicos com Pontes / Proteínas Proto-Oncogênicas c-bcl-2 / Sinergismo Farmacológico / Classe I de Fosfatidilinositol 3-Quinases Idioma: En Ano de publicação: 2019 Tipo de documento: Article